VANCOUVER, British Columbia, Dec. 15 /PRNewswire-FirstCall/ -- The following was issued today by Robert Kramer, Director, Current Technology Corporation :
Current Technology is pleased to report that Douglas Beder, Ph.D., of Vancouver, British Columbia has joined its Board of Directors. Dr. Beder, Professor Emeritus, Department of Physics & Astronomy, University of British Columbia brings a broad range of knowledge and experience to the Board of Current Technology. Shortly after earning his undergraduate degree (Honors Mathematics and Physics) from McGill University, Montreal and his Ph.D. in theoretical physics from the California Institute of Technology, Dr. Beder went on to teach at the University of British Columbia. At UBC, Professor Beder also undertook both research and academic responsibilities including Faculty of Science Coordinator for the University Industry Liaison Office.
Dr. Beder has also held, at various times, research appointments to several international centers including the Los Alamos National Laboratory, Lawrence Radiation Laboratory, Berkeley, California and the European Center for Nuclear Research, Geneva, Switzerland. A consultant to Current Technology since 1991, Dr. Beder has been intimately involved in the development of its patented TrichoGenesis platform and production of both ElectroTrichoGenesis and CosmeticTrichoGenesis units. He continues to be actively involved in the technology of the TrichoGenesis platform and plays an important role in the Quality Assurance program.
"Dr Beder has been a valuable member of the Current Technology team for a number of years and we are delighted he has agreed to join the Board," states CEO Robert Kramer. "He is a man of superior intelligence and brings a wealth of knowledge and experience to the position."
Dr. Beder will join Peter Bell (Chair) and Robert Kramer on the Audit Committee.
About Current Technology Corporation
Current Technology Corporation remains committed to developing its non-invasive pulsed electro-stimulation technology. This technology has enabled the company to develop two separate and distinct products emanating from the TrichoGenesis platform, thus far, that offer help for those concerned with their hair: ElectroTrichoGenesis (ETG) and CosmeticTrichoGenesis (CTG). Current Technology holds patents throughout the world and has spent over US $15 million in research and development of its TrichoGenesis platform and systems. The patents encompass the technology, methodology and design of the company's products.
Current Technology CorporationCONTACT: corporate, Robert Kramer of Current Technology Corporation,800-661-4247, +1-604-684-2727, or rkramer@current-technology.com; orinvestors, Richard Hannon of Polestar Communications, 866-858-4100, forCurrent Technology Corporation
Web site: http://www.current-technology.com/
